Annual | 12/2023FY | 12/2024FY |
---|---|---|
Total Revenue | $100.33 B | $58.5 B |
Net Income | $31.37 B | $2.13 B |
Quarterly | 6/30/2023 | 9/30/2023 |
Total Assets | $220.17 B | $215.02 B |
Total Liabilities | $117.82 B | $137.21 B |
Operating Margin | 16.32% | -24.68% |
Pfizer Inc.
66 Hudson Boulevard East |
|
Industry | Pharmaceuticals: Major |
---|---|
Sector | Health Technology |
Employees | 88,000 |
Dr. Albert Bourla | Mr. David M. Denton | Dr. Luis Jodar | |||||||||||||||||||||||||||||
Chairman & Chief Executive Officer | Chief Financial Officer & Executive Vice President | Chief Medical Officer-Vaccines & Senior VP | |||||||||||||||||||||||||||||
Dr. William C. Sessa | Dr. Annaliesa Anderson | Dr. Mikael Dolsten | Ms. Lidia L. Fonseca | Dr. Aida Habtezion | Dr. Maria Rivas | Dr. Jeff Settleman | Dr. Helen H. Hobbs | Dr. Scott Gottlieb | Mr. Shantanu Narayen | Mr. Shantanu Narayen | Dr. Albert Bourla | Mr. James C. Smith | Mr. James C. Smith | Mr. Joseph J. Echevarria | Mr. Joseph J. Echevarria | Mr. Ronald Edward Blaylock | Mr. Ronald Edward Blaylock | Dr. Dan R. Littman | Dr. Dan R. Littman | Dr. Helen H. Hobbs | Dr. Scott Gottlieb | Ms. Suzanne Nora Johnson | Ms. Suzanne Nora Johnson | Mr. James Quincey | Mr. James Quincey | Dr. Susan J. Hockfield | Dr. Susan J. Hockfield | Dr. Susan D. Desmond-Hellmann | Dr. Susan D. Desmond-Hellmann | Ms. Margaret M. Madden | |
SVP &Chief Scientific Officer-Internal Medicine | SVP, Head-Vaccine Research & Development | Co-Chief Scientific Officer & President-Research | Executive VP, Chief Technology & Digital Officer | Chief Medical Officer & Head-Worldwide Medical | Chief Medical Affairs Officer | Co-Chief Scientific Officer | Independent Director | Independent Director | Lead Independent Director | Lead Independent Director | Chairman & Chief Executive Officer | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Independent Director | Secretary, Chief Governance Counsel & Senior VP |
Company Name | Price | EPS (FY) | Annual Dividend | Book Value (FY) | Cash Flow (FY) |
---|---|---|---|---|---|
Pfizer Inc. | $25.26 | 0.38 | 1.65 | 15.77 | 1.93 |